With Pfizer Firmly in Value Territory, Here's What Investors Are Missing

Investors have faced a conundrum in valuing companies that benefited from the Covid-19 pandemic. Pfizer's (PFE) partnership with BioNTech (BNTX) in creating a vaccine, plus its antiviral, Paxlovid, materially boosted earnings and its balance sheet over the last two years. The market has already…

#pfe #bntx #pfizer #remarkably #ubs #eps #bankofamerica #rsv #glp1 #elililly